In this session, the faculty will summarize, and review screening recommendations issued by the USPSTF, prioritizing the most significant and controversial topics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 6, 2020, and they are subject to change as new information is published.

This lecture will discuss the appropriate follow-up of patients treated for the most common cancers. This will include breast cancer, colorectal cancer, Hodgkin's and non-Hodgkin's lymphoma, prostate cancer, and lung cancer. An in-depth discussion of the physical challenges and psychological impacts of a cancer diagnosis and its treatment will prepare you to help your patients with what lies ahead.

This session will discuss the latest guidelines and best practices in caring for the LGBTQ community. You will walk away with resources to improve your practice and provide to your patients.

This talk will review recent screening recommendations from the United States Preventive Services Task Force (USPSTF). As well as presenting evidence behind new screening modalities, the faculty will review considerations for deciding whether or not to screen. Additionally, you will walk away from this practical session with strategies to communicate screening results sensitively. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020, and they are subject to change as new information is published.

Screening recommendations issued by the USPSTF in the past year will be summarized and reviewed. The most significant and controversial topics will be prioritized. Within the past year, the USPSTF has issued screening recommendation statements on the following topics: cervical, prostate, and ovarian cancer; osteoporosis; CVD; atrial fibrillation; syphilis among pregnant women; adolescent idiopathic scoliosis; and vision problems among young children.

Screening of the young athlete ranges from questionnaires to advanced cardiovascular diagnostic testing. The risk of disease in this population is quite low, yet each event has devastating consequences to families and communities. Prevention of even one event makes such clear moral sense that we feel obligated to employ any and all available tools that could possibly help do just that. It is important that we understand the tools available and that we use them effectively to save as many susceptible young lives as possible. It will be the goal of this talk to best understand the tools available with their advantages and disadvantages. We will also discuss the controversies surrounding these population health screening programs.

Genetics is increasingly utilized in healthcare. From the medical office to the home, consumer-focused over-the-counter (OTC) testing is now common-place. The challenge for the primary care clinician is to not only understand the types of genetics tests available and when to order them but also to respond appropriately to patients who have obtained OTC results on their own. While medical geneticists are available for consultation, the sheer volume of testing requires primary clinicians to develop a level of comfort with genomics.

Over the past 20 years, there has been push back from patients about vaccines. This has been driven by concerns about vaccine safety promoted by the media, celebrities, and (now retracted) scientific reviews. As a result, there have been numerous outbreaks of rare, vaccine preventable infections. There has been a resurgence of mumps, pertussis and respiratory syncytial virus infections. Currently the United States is facing growing numbers of measles cases. These infections put the most vulnerable patients at risk of serious morbidity and mortality. All clinicians should understand what is true and untrue about the anti-vaccine controversy and how to discuss the benefits and risks of vaccination with their patients. Clinicians should also be aware of the most updated adult vaccine recommendations by the CDC and ACIP and ensure their patients are vaccinated properly. Given the recent resurgence of measles, clinicians should also be able to recognize a case of measles, how to diagnose and care for patients with suspected measles, and how to report a case to their local public health department.

We will discuss the diagnosis and management of enlarged prostate, and when to order a prostate-specific antigen test. The speaker will elaborate on the diagnosis and management of enlarged prostate. Learners will walk away with improved confidence in knowing when to order a prostate-specific antigen test.

Guidelines for immunizations and cancer screening recommendations are constantly in flux as new data emerges. This session will review some current recommendations for vaccinations and cancer screening in children and adults in addition to controversies related to these recommendations.

Join us as we discuss a recent report in the British Medical Journal that reviewed data on the effectiveness of colorectal cancer screening programs and presented new guidelines which recommend a “shared decision-making model" and that individuals with an estimated 15-year colorectal cancer risk below 3% undergo no screening at all! This session will review the recently published guidelines to understand the data behind their recommendations and discuss how best to implement such an approach in your practice.

Join us as we discuss HPV vaccination and the growing evidence of the benefits to those who receive the vaccine and the protection of those who are not vaccinated.